ShopSpell

Biopharmaceutical Informatics: Learning to Discover Developable Biotherapeutics [Hardcover]

$196.99       (Free Shipping)
104 available
  • Category: Books (Science)
  • ISBN-10:  1032291672
  • ISBN-10:  1032291672
  • ISBN-13:  9781032291673
  • ISBN-13:  9781032291673
  • Publisher:  CRC Press
  • Publisher:  CRC Press
  • Pages:  384
  • Pages:  384
  • Binding:  Hardcover
  • Binding:  Hardcover
  • SKU:  1032291672-11-MPOD
  • SKU:  1032291672-11-MPOD
  • Item ID: 107073980
  • Seller: ShopSpell
  • Ships in: 2 business days
  • Transit time: Up to 5 business days
  • Delivery by: Oct 10 to Oct 12
  • Notes: Brand New Item. Not shipped to AK, HI, APO, FPO, AE.

Foreword
Preface
About the editors
List of contributors

1. Biopharmaceutical Informatics: An Introduction

2. Digital transformation in the biopharmaceutical industry: rebuilding the way we discover complex therapeutics

3. Computational protein design strategies for optimization of antigen generation to drive antibody discovery

4. Bioinformatic Analyses of Antibody Repertoires and Their Roles in Modern Antibody Drug Discovery

5. Applications of Artificial Intelligence and Machine Learning Towards Antibody Discovery and Development

6. From Deep Generative Models to Structure-Based Simulations: Computational Approaches for Antibody Design

7. Computational biophysical analyses of antibody structure-function relationships with emphasis on therapeutic antibody-based biologics

8. Use of molecular simulations to understand structural dynamics of antibodies

9. Considerations of developability during the early stages of antibody drug discovery and design

10. In Silico Approaches to Deliver Better Antibodies by Design  The Past, the Present and the Future

11. Use of systems biology approaches towards target discovery, validation, and drug development

12. Recent advances in PK/PD and Quantitative Systems Pharmacology (QSP) models for biopharmaceuticals

13. The Artificial Intelligence Revolution: Transforming the Design and Optimization of Multispecific Antibodies

Index.

This book describes ways to invent and commercialize biomedicines in a more time and cost-efficient manner. Failure to translate a discovery into a marketed drug denies us an opportunity to improve the lives of patients who do not have access to effective therapies. Here, the authors provide a greater understandinló+
Add Review